<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00185783</url>
  </required_header>
  <id_info>
    <org_study_id>95230</org_study_id>
    <secondary_id>Stanford IRB Number 4593</secondary_id>
    <secondary_id>Other Grant</secondary_id>
    <nct_id>NCT00185783</nct_id>
  </id_info>
  <brief_title>Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis</brief_title>
  <official_title>Pilot Study of White Blood Cell Gene Expression in Critically Ill Patients With Severe Sepsis and Relative Adrenal Insufficiency After Hydrocortisone Administration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to (1) examine the changes in gene expression in patients
      who suffer from severe sepsis and whose shock (inadequate oxygen delivery to vital organs)
      state does not respond to fluid and vasopressor administration, (2) to show that our sampling
      method of isolating RNA provides reliable and consistent data, (3) provide a basis for future
      gene expression studies in critically ill patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Severe sepsis is characterized by inadequate perfusion of vital organs due to infection. More
      than 750,000 cases of severe sepsis occur each year in the United States. Mortality among
      patients with severe sepsis ranges from 7% to 50%. Initiation of antibiotic therapy within
      the first hour of diagnosis as well as fluid resuscitation and hemodynamic stabilization are
      primary goals of therapy.

      Steroid administration has been shown to improve outcome in the subset of severe sepsis
      patients suffering from relative adrenal insufficiency. Although initial studies using high
      dose short course steroid therapy did not demonstrate efficacy, more recent studies of low
      dose longer duration hydrocortisone administration demonstrated a significant reduction in
      mortality at 28 days. The mechanism by which steroid administration affords protection is
      unclear. We hypothesize that steroid administration changes white blood cell gene and protein
      expression in severe sepsis patients from an immuno-inflammatory profile to a pattern
      consistent with healing.

      Our first specific aim is to obtain plasma and total cellular RNA from leukocytes in the
      blood of ten patients admitted to Stanford Medical Center with the diagnosis of severe sepsis
      and adrenal insufficiency. Significant and distinct variations in whole blood leukocyte gene
      expression patterns occur depending upon the method of RNA isolation. We will attempt to
      demonstrate that our sampling method provides reliable and consistent data.

      Our second specific aim is to begin an analysis of gene expression patterns in white blood
      cells before and after steroid administration in patients suffering from severe sepsis with
      relative adrenal insufficiency. We will use a protocol for assessment of gene expression that
      was developed by members of our research team.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <primary_completion_date type="Actual">November 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">10</enrollment>
  <condition>Sepsis</condition>
  <condition>Relative Adrenal Insufficiency</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone Administration (Standard of Care Therapy)</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to the Stanford Hospital ICU with Sepsis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission Diagnosis of Sepsis

          -  Evidence of Relative Adrenal Insufficiency

          -  Hypotension (Mean Arterial Pressure less than 60 mm Hg) Refractory to a. Fluid
             Resuscitation b. Dopamine infusion (greater than 5 micrograms/kg/min) c. Phenylephrine
             infusion (greater than 1 microgram/kg/min)

        Exclusion Criteria:

          -  Use of Immunosuppressant Medications

          -  Immune Compromised Due to Disease (e.g., HIV infection)

          -  Transfusion of Blood Products within the past 7 Days

          -  Use of Cytokine Therapy (i.e., G-CSF)

          -  History of Bone Marrow Transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew J Patterson, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University, Dept. of Anesthesia, Division of Critical Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ann Weinacker, M.D.,</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University, Dept. of Medicine, Div. of Pulmonary and Critical Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Spiegelman JI, Mindrinos MN, Oefner PJ. High-accuracy DNA sequence variation screening by DHPLC. Biotechniques. 2000 Nov;29(5):1084-90, 1092.</citation>
    <PMID>11084871</PMID>
  </reference>
  <reference>
    <citation>Steinmetz LM, Mindrinos M, Oefner PJ. Combining genome sequences and new technologies for dissecting the genetics of complex phenotypes. Trends Plant Sci. 2000 Sep;5(9):397-401.</citation>
    <PMID>10973096</PMID>
  </reference>
  <reference>
    <citation>Wang QT, Piotrowska K, Ciemerych MA, Milenkovic L, Scott MP, Davis RW, Zernicka-Goetz M. A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo. Dev Cell. 2004 Jan;6(1):133-44.</citation>
    <PMID>14723853</PMID>
  </reference>
  <reference>
    <citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004 Mar;32(3):858-73. Review. Erratum in: Crit Care Med. 2004 Oct;32(10):2169-70. Crit Care Med. 2004 Jun;32(6):1448. Dosage error in article text.</citation>
    <PMID>15090974</PMID>
  </reference>
  <reference>
    <citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004 Apr;30(4):536-55. Epub 2004 Mar 3.</citation>
    <PMID>14997291</PMID>
  </reference>
  <reference>
    <citation>Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003 Mar;31(3):946-55. Review.</citation>
    <PMID>12627010</PMID>
  </reference>
  <reference>
    <citation>Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002 Aug 21;288(7):862-71. Erratum in: JAMA. 2008 Oct 8;300(14):1652. Chaumet-Riffaut, Philippe [corrected to Chaumet-Riffaud, Philippe].</citation>
    <PMID>12186604</PMID>
  </reference>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>April 7, 2011</last_update_submitted>
  <last_update_submitted_qc>April 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Andrew J. Patterson, M.D., Ph.D.</name_title>
    <organization>Stanford University</organization>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Adrenal Insufficiency</keyword>
  <keyword>Hydrocortisone</keyword>
  <keyword>Gene Expression</keyword>
  <keyword>Microarray</keyword>
  <keyword>RNA</keyword>
  <keyword>Critically Ill</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Adrenal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

